5:45 PM
Oct 16, 2012
 |  BC Extra  |  Company News

Kite in T cell therapy deal with NCI

Kite Pharma Inc. (Los Angeles, Calif.) announced a deal with NIH's National Cancer Institute for exclusive access to NCI's pipeline of of engineered autologous T cell therapeutics. Kite also received...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >